Terms: = Thyroid cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4
18088 results:
1. Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review.
Zhao H; Kang W; Guan J; Wang Y
Medicine (Baltimore); 2024 May; 103(20):e38237. PubMed ID: 38758843
[TBL] [Abstract] [Full Text] [Related]
2. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of thyroid cancer.
Fu G; Chazen RS; MacMillan C; Witterick IJ
JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
[TBL] [Abstract] [Full Text] [Related]
3. Trends and projections of the global burden of thyroid cancer from 1990 to 2030.
Hu S; Wu X; Jiang H
J Glob Health; 2024 May; 14():04084. PubMed ID: 38751316
[TBL] [Abstract] [Full Text] [Related]
4. A CT based radiomics analysis to predict the CN0 status of thyroid papillary carcinoma: a two- center study.
Li Z; Zhong Y; Lv Y; Zheng J; Hu Y; Yang Y; Li Y; Sun M; Liu S; Guo Y; Zhang M; Zhou L
Cancer Imaging; 2024 May; 24(1):62. PubMed ID: 38750551
[TBL] [Abstract] [Full Text] [Related]
5. Feasibility and complications after transoral endoscopic thyroidectomy via vestibular approach (TOETVA) - a single-center first experience case series.
Kinet S; van Weezelenburg MAS; Pijnenburg A; Stoot JHMB; van Bastelaar J
Langenbecks Arch Surg; 2024 May; 409(1):158. PubMed ID: 38748236
[TBL] [Abstract] [Full Text] [Related]
6. Coexistence of Hashimoto's thyroiditis and papillary thyroid carcinoma revisited in thyroidology, an experience from an endemic region: fad or future?
Cinar I; Sengul I
Rev Assoc Med Bras (1992); 2024; 70(4):e20231380. PubMed ID: 38747877
[TBL] [Abstract] [Full Text] [Related]
7. [Imaging characteristics and diagnosis of primary middle mediastinal tumors].
Chen JQ; Wang JW
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):449-456. PubMed ID: 38742358
[No Abstract] [Full Text] [Related]
8. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
[TBL] [Abstract] [Full Text] [Related]
9. Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity.
Ballico M; Alessi D; Aneggi E; Busato M; Zuccaccia D; Allegri L; Damante G; Jandl C; Baratta W
Molecules; 2024 May; 29(9):. PubMed ID: 38731639
[TBL] [Abstract] [Full Text] [Related]
10. In situ ascending aortic thrombus in a patient with metastatic lung adenocarcinoma and no aortic atherosclerosis or cisplatin exposure: a case report.
Mehta C; Raza F
J Med Case Rep; 2024 May; 18(1):243. PubMed ID: 38730499
[TBL] [Abstract] [Full Text] [Related]
11. Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing.
Zheng K; Zhang XX; Yu X; Yu B; Yang YF
Medicine (Baltimore); 2024 May; 103(19):e38144. PubMed ID: 38728457
[TBL] [Abstract] [Full Text] [Related]
12. Low TSH and low T3 hormone levels as a prognostic for mortality in COVID-19 intensive care patients.
Sror-Turkel O; El-Khatib N; Sharabi-Nov A; Avraham Y; Merchavy S
Front Endocrinol (Lausanne); 2024; 15():1322487. PubMed ID: 38726342
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
[TBL] [Abstract] [Full Text] [Related]
14. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract] [Full Text] [Related]
15. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
16. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
[TBL] [Abstract] [Full Text] [Related]
17. Identification and Economic Evaluation of Differentiated thyroid cancer Care Consumption Patterns Using Sequence Analysis.
Demeulemeester R; Grosclaude P; Grunenwald S; Saint-Pierre P; Savy N; Costa N
Int J Public Health; 2024; 69():1606664. PubMed ID: 38707870
[No Abstract] [Full Text] [Related]
18. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
[TBL] [Abstract] [Full Text] [Related]
19. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract] [Full Text] [Related]
20. Feasibility and safety of modified en-bloc resection in endoscopic thyroid surgery via bilateral areolar approach - long-term institutional analysis ten years after surgery.
Xie Q; Ma J; Du Y; Liu L; Zhu R; Liu D; Wang P; Yu X
Front Endocrinol (Lausanne); 2024; 15():1302510. PubMed ID: 38694946
[TBL] [Abstract] [Full Text] [Related]
[Next]